July 03, 2026 a 04:38 pm
CNC: Analysts Ratings - Centene Corp.
Centene Corp., a managed care company, has caught the attention of analysts due to its diverse operations across Medicaid, Medicare, and commercial sectors. Currently, analysts are showing a cautious outlook with a predominance of 'Hold' recommendations. However, a few analysts maintain a bullish stance, reflecting confidence in the company's adaptability in the evolving healthcare landscape.
Historical Stock Grades
Over the recent months, the stock grades for Centene Corp have shown a considerable leaning towards cautious recommendations. The ratings for July 2026 are indicative of the prevailing sentiment:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 6 | |
| Hold | 13 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment around Centene's stock ratings has shown a clear shift towards neutral to hold recommendations. Over the past months:
- The number of 'Strong Buy' recommendations dwindled from a high of 6 in 2023 to 1 by mid-2026.
- 'Hold' recommendations have consistently been the majority, indicating a cautious stance from analysts.
- Buy ratings remain stable with minor fluctuations, reflecting a steady but subdued optimism.
Percentage Trends
Over the last few quarters, a reduction in 'Strong Buy' ratings is notable, with more analysts opting for a 'Hold'. The percentage distribution outlines:
- 'Strong Buy' declined from over 20% in early 2024 to under 5% by mid-2026.
- 'Hold' ratings represented a significant portion, increasing from 10% to 65% over the same period.
- Buy recommendations displayed minor declines, maintaining around 30% of overall sentiment.
Latest Analyst Recommendations
Recent analyst actions maintain the status quo, with no new ratings deviating significantly from previous stances:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-08 | Neutral | Neutral | JP Morgan |
| 2026-06-08 | Neutral | Neutral | Mizuho |
| 2026-06-04 | Buy | Buy | B of A Securities |
| 2026-06-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2026-06-01 | Buy | Buy | Truist Securities |
Analyst Recommendations with Change of Opinion
Several analysts demonstrated a change in outlook earlier in the year, indicating a shift in sentiment:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-05-20 | Buy | Hold | Deutsche Bank |
| 2026-04-29 | Buy | Underperform | B of A Securities |
| 2026-04-29 | Overweight | Neutral | Cantor Fitzgerald |
| 2026-01-05 | Overweight | Equal Weight | Barclays |
| 2025-07-28 | Neutral | Overweight | Cantor Fitzgerald |
Interpretation
The present market outlook for Centene Corp. suggests caution with notable reliance on 'Hold' recommendations, reflecting uncertainty and risk aversion among analysts. The occasional upgrade indicates selective confidence in potential growth areas within managed care. Overall, sentiment stability is moderate, with potential fluctuations driven by sector innovations or policy shifts.
Conclusion
In conclusion, the analysis of Centene Corp's ratings reveals a cautious optimism with predominant 'Hold' stances, indicative of current market uncertainties in the managed healthcare sector. While recent months observed some bullish signals, consistent analyst sentiment suggests the company is perceived as a stable but not aggressively growing entity. Investors need to weigh potential upside opportunities in Medicaid and Medicare segments against prevailing concerns about the broader economic climate.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years